Trypanosoma rangeli Tejera, 1920, in chronic Chagas' disease patients under ambulatory care at the Evandro Chagas Clinical Research Institute (IPEC—Fiocruz, Brazil)

Author： Sousa Maria  

Publisher： Springer Publishing Company

ISSN： 0932-0113

Source： Parasitology Research, Vol.103, Iss.3, 2008-08, pp. : 697-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy of chronic indeterminate Chagas disease: a novel approach to treatment

By Bazán Paola  

Parasitology Research, Vol. 103, Iss. 3, 2008-08 ,pp. : 663-669

Springer Publishing Company

Access to resources Recommend Favorite

Capillary damage in skeletal muscle in advanced Chagas’ disease patients

By Torres Sonia   Finol Héctor   Montes de Oca María   Vásquez Francia   Puigbó Juan   Loyo José  

Parasitology Research, Vol. 93, Iss. 5, 2004-08 ,pp. : 364-368

Springer Publishing Company

Access to resources Recommend Favorite

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions

By Caldas Ivo  

Parasitology Research, Vol. 103, Iss. 2, 2008-07 ,pp. : 413-421

Springer Publishing Company

Access to resources Recommend Favorite

Fungal flora of the digestive tract of 5 species of triatomines vectors of Trypanosoma cruzi, Chagas 1909

By Moraes A.M.L.   Junqueira A.C.V.   Costa G.L.   Celano V.   Oliveira P.C.   Coura J.R.  

Mycopathologia, Vol. 151, Iss. 1, 2001-06 ,pp. : 41-48

Springer Publishing Company

Access to resources Recommend Favorite

Whac-a-mole: future trends in Chagas transmission and the importance of a global perspective on disease control

By Dorn Patricia   Buekens Pierre   Hanford Elaine  

Future Microbiology, Vol. 2, Iss. 4, 2007-08 ,pp. : 365-367

Future Medicine

Access to resources Recommend Favorite